Instant Access with secure payment processing: $195 / One Month $750 / One Year Need an invoice? Group rate? Contact admin@DrugPatentWatch.com

Listing of Drug Product Information by Patent Expiration - 2011

Range: 1 - 5

Applicant Tradename Generic Name NDA Approval Date Type Patent Number Patent Expiration Patented / Exclusive Use Pharmacia And Upjohn AROMASIN exemestane 020753 Oct 21, 1999 RX 4,808,616 Apr 1, 2011 TREATMENT OF ADVANCED HORMONE-DEPENDENT BREAST CANCER Merck COSOPT dorzolamide hydrochloride; timolol maleate 020869 Apr 7, 1998 RX 6,248,735 Apr 17, 2011 Merck COSOPT dorzolamide hydrochloride; timolol maleate 020869 Apr 7, 1998 RX 6,316,443 Apr 17, 2011 COSOPT IS INDICATED FOR THE REDUCTION OF ELEVATED INTRAOCULAR PRESSURE IN PATIENTS WITH OPEN-ANGLE GLAUCOMA OR OCULAR HYPERTENSION WHO ARE INSUFFICIENTLY RESPONSIVE TO BETA BLOCKERS Astrazeneca ATACAND candesartan cilexetil 020838 Jun 4, 1998 RX 5,705,517 Apr 18, 2011 TREATMENT OF HYPERTENSION AND TREATMENT OF HEART FAILURE Astrazeneca ATACAND HCT candesartan cilexetil; hydrochlorothiazide 021093 May 16, 2008 RX 5,705,517 Apr 18, 2011 TREATMENT OF HYPERTENSION

 Complete access available with subscription